• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Rimidi Partners with USC to Improve Postpartum Care for High-Risk Mothers

by Jasmine Pennic 06/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Rimidi, a leading digital health company specializing in remote patient monitoring, announced a new partnership with the University of South Carolina (USC) and an affiliated multispecialty clinic. Funded by The Duke Endowment, this initiative aims to improve postpartum care and outcomes for mothers in underserved communities, particularly those with high-risk pregnancies.

– The strategic collaboration brings together USC’s research expertise, Rimidi’s advanced technology, and the clinic’s patient care experience. By focusing on remote monitoring and early intervention, they aim to significantly improve postpartum care, leading to better health outcomes for mothers and their newborns.

Addressing Disparities in Postpartum Care

The state of South Carolina faces a significant challenge in maternal health. Regions with limited access to healthcare experience a disproportionate burden of hypertensive disorders, like preeclampsia and gestational hypertension, during pregnancy. These complications can persist postpartum and contribute to negative health outcomes. A recent report revealed a troubling statistic – South Carolina has a maternal mortality rate of 32.7 deaths per 100,000 births.

The Power of Remote Patient Monitoring

This new partnership leverages Rimidi’s innovative remote patient monitoring (RPM) platform. Integrated with the clinic’s existing Epic electronic health record (EHR), the platform streamlines data management and provides healthcare providers with real-time access to critical patient information. This facilitates proactive intervention and allows for timely adjustments to hypertension management plans.

Focus on Maternal Wellbeing

With a focus on maintaining safe blood pressure levels after delivery, the program will monitor key metrics such as:

  • Blood pressure readings within the first six weeks postpartum
  • Attendance at in-person follow-up appointments
  • Hospital readmission rates within the first year after birth
  • Overall program acceptability, retention, and patient satisfaction
  • Cost-effectiveness of the RPM program
    pen_spark
“Our partnership with the University of South Carolina is deeply rooted in our commitment to helping postpartum mothers receive the care they need during a critical transition period in their lives,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “By leveraging Rimidi’s RPM platform, new mothers will be better monitored by their providers, which allows them to keep track of their blood pressure in real-time, ensuring timely and proactive management of hypertension – while minimizing the separation from their new child.”
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Care Coordination, Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |